Avita Medical Ltd Cash Flow Conversion Efficiency
Avita Medical Ltd cash flow conversion efficiency. Based on the latest financial reports, Avita Medical Ltd (RCEL) has a cash flow conversion efficiency ratio of 0.327x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.44 Million) by net assets ($-16.65 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Avita Medical Ltd stock valuation for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Avita Medical Ltd (1993–2025)
Cash flow conversion efficiency of Avita Medical Ltd from 1993 to 2025. This chart illustrates how Avita Medical Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Avita Medical Ltd (RCEL) stock price for real-time trading data and today's change.
Avita Medical Ltd Cash Flow Conversion Ratio Explained
Avita Medical Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Avita Medical Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avita Medical Ltd ranked by their cash flow conversion efficiency. Review cash generation quality of Avita Medical Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bastas Baskent Cimento Sanayi ve Ticaret AS
IS:BASCM
|
0.160x |
|
TRUFIN PLC
F:29U
|
N/A |
|
Grigeo AB
STU:WM8
|
0.060x |
|
Group Eleven Resources Corp
V:ZNG
|
-0.080x |
|
King Chou Marine Technology Co Ltd
TWO:4417
|
0.007x |
|
Grupo Clarin S.A.
BA:GCLA
|
-0.134x |
|
Hyloris Developmentsen Sa
BR:HYL
|
-0.058x |
|
Caisse Reg Cred Agric Mut Tourain Poitou
PA:CRTO
|
-0.020x |
Annual Cash Flow Conversion Efficiency for Avita Medical Ltd (1993–2025)
The table below shows the annual cash flow conversion efficiency of Avita Medical Ltd from 1993 to 2025. Also see how large is Avita Medical Ltd's balance sheet for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-16.65 Million | $-31.20 Million | 1.874x | +117.22% |
| 2024-12-31 | $4.50 Million | $-48.94 Million | -10.878x | -1303.85% |
| 2023-12-31 | $49.06 Million | $-38.01 Million | -0.775x | -243.95% |
| 2022-12-31 | $84.74 Million | $-19.09 Million | -0.225x | -30.67% |
| 2021-12-31 | $104.62 Million | $-18.04 Million | -0.172x | +45.13% |
| 2020-12-31 | $72.40 Million | $-22.75 Million | -0.314x | +66.00% |
| 2019-12-31 | $20.83 Million | $-19.25 Million | -0.924x | -83.92% |
| 2017-12-31 | $18.99 Million | $-9.54 Million | -0.502x | +60.87% |
| 2016-12-31 | $5.12 Million | $-6.58 Million | -1.284x | -48.41% |
| 2015-12-31 | $6.85 Million | $-5.93 Million | -0.865x | +25.13% |
| 2014-12-31 | $4.22 Million | $-4.87 Million | -1.155x | +1.84% |
| 2013-12-31 | $5.53 Million | $-6.51 Million | -1.177x | -83.67% |
| 2012-12-31 | $10.46 Million | $-6.70 Million | -0.641x | -27.02% |
| 2011-12-31 | $8.55 Million | $-4.32 Million | -0.505x | -174.05% |
| 2010-12-31 | $16.99 Million | $-3.13 Million | -0.184x | +46.35% |
| 2009-12-31 | $3.98 Million | $-1.36 Million | -0.343x | +36.51% |
| 2008-12-31 | $6.93 Million | $-3.75 Million | -0.541x | -97.65% |
| 2007-12-31 | $12.96 Million | $-3.54 Million | -0.273x | +60.53% |
| 2006-12-31 | $10.98 Million | $-7.60 Million | -0.693x | -6.46% |
| 2005-12-31 | $11.15 Million | $-7.26 Million | -0.651x | -69.41% |
| 2004-12-31 | $13.09 Million | $-5.03 Million | -0.384x | +21.56% |
| 2003-12-31 | $8.66 Million | $-4.24 Million | -0.490x | -304.84% |
| 2002-12-31 | $8.25 Million | $-997.61K | -0.121x | -67.46% |
| 2001-12-31 | $4.53 Million | $-327.44K | -0.072x | +16.82% |
| 2000-12-31 | $5.38 Million | $-467.41K | -0.087x | +42.40% |
| 1999-12-31 | $2.72 Million | $-409.81K | -0.151x | -0.12% |
| 1998-12-31 | $1.10 Million | $-166.28K | -0.151x | -24.15% |
| 1997-12-31 | $1.78 Million | $-215.74K | -0.121x | -16.34% |
| 1996-12-31 | $4.98 Million | $-519.14K | -0.104x | -17.25% |
| 1995-12-31 | $4.48 Million | $-398.66K | -0.089x | +9.97% |
| 1994-12-31 | $5.82 Million | $-574.61K | -0.099x | -2049.66% |
| 1993-12-31 | $6.55 Million | $33.17K | 0.005x | -- |
About Avita Medical Ltd
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitili… Read more